Stock Market Update - January 29, 2026
Today's stock market saw some significant movers. Here's a breakdown of 5 stocks that caught our attention:
1. TCGL - TechCreate Group Ltd.
Price: $86.36 | Change: +889.23% ($77.63)
TCGL saw an incredible jump of 889.23% by late January 2026, fueled by a series of strategic corporate moves and strong financial performance. A key catalyst was the company's recent acquisition of FreeNow in Europe, a move expected to significantly expand its footprint in the European rideshare market and broaden its service offerings, generating positive investor sentiment.
Adding to the positive momentum, TechCreate's latest financial reports showcased improved revenue streams, recently reaching $3.1 million, and robust balance sheets. The company also benefited from its successful Initial Public Offering (IPO) in October 2025, which raised $10.2 million and saw an immediate 21% rise on its debut. The executive leadership team even celebrated this milestone by ringing The Opening Bell® at the New York Stock Exchange.
What makes TechCreate's surge particularly interesting is how it effectively combined a successful market debut with aggressive strategic acquisitions and solid financial fundamentals in a relatively short timeframe, capturing significant investor attention.
2. RPGL - Republic Power Group Limited Class A Ordinary Shares
Price: $0.8821 | Change: +173.86% ($0.56)
RPGL rocketed to an incredible 173.86% gain around late January 2026, grabbing significant attention. This substantial surge was primarily driven by Republic Power Group's announcement of a new stock offering designed to raise capital for key growth initiatives like research and development, marketing, and potential acquisitions. The company planned to issue up to 50,000,000 new Class A Ordinary Shares at a fixed price of $0.20 each.
While typically, issuing so many new shares can dilute existing shareholders, this particular offering was perceived as a lifeline. It aimed to secure much-needed funds, especially after the company received a Nasdaq notification for its share price falling below the minimum $1.00 requirement. Market reaction was swift and positive, with a "sharp intraday rally" on high trading volume, suggesting strong speculative interest propelled the shares higher despite the dilutive nature.
This case is interesting because a highly dilutive offering, often viewed with skepticism, instead fueled a massive surge. It illustrates how the market can react to the prospect of new capital and potential future growth, even when accompanied by a significant increase in outstanding shares.
3. ANL - Adlai Nortye Ltd.
Price: $6.53 | Change: +88.18% ($3.06)
ANL saw its stock jump an impressive 88.18% on January 29, 2026. This significant move for Adlai Nortye Ltd. came after Lucid Capital Markets initiated coverage with a "Buy" rating and an $11.00 price target. The positive outlook centered on AN9025, the company's pan-RAS inhibitor, which analysts projected could generate billions in peak revenues.
This bullish analyst view built upon an earlier strategic move: Adlai Nortye's December 2025 exclusive licensing agreement with ASK Pharm for AN9025. This deal, valued at up to $230 million, grants ASK Pharm rights to develop and commercialize the drug in China, Hong Kong, and Macao, while Adlai Nortye keeps global rights. The combination of this strategic partnership, the analyst's optimistic valuation, and a noticeable decrease in short interest likely fueled the strong upward momentum.
4. LNKS - Linkers Industries Limited
Price: $1.32 | Change: +71.50% ($0.5503)
LNKS captivated investors with an impressive 71.50% surge, pushing its stock to a 52-week high of $1.32 on January 29, 2026. This significant jump wasn't directly attributed to a specific company press release or a new partnership announcement. Instead, reports suggested that "positive market sentiment" played a key role in driving Linkers Industries Limited's performance.
This wasn't an isolated event, as LNKS had already seen considerable gains earlier in the week, accumulating daily increases of over 35%. The cumulative positive momentum helped propel the stock to its highest levels in a year. What makes this move particularly interesting is how broader market enthusiasm, rather than a single, disclosed corporate event, fueled such a substantial rise.
5. FEED - NanoVibronix, Inc. Common Stock
Price: $3.84 | Change: +66.96% ($1.54)
FEED saw a significant jump, gaining 66.96% around late January, primarily due to a series of strategic commercialization announcements from ENvue Medical, Inc. (now trading under the FEED ticker). The most impactful news was a major distribution partnership designed to expand the reach of their medical devices.
On January 28, 2026, the company announced a strategic distribution agreement with U-Deliver, a U.S. provider, to nationally distribute ENvue's new over-the-counter (OTC) reusable ENFit syringes. These non-prescription syringes, launched just weeks prior, are designed for multiple uses to create a recurring revenue stream, specifically targeting non-acute care settings like home and long-term care facilities. This, coupled with a new program for their proprietary low-intensity surface acoustic wave (SAW) technology, contributed to the positive sentiment.
What makes this surge particularly interesting is the clear signal of a strengthened commercial strategy. New leadership appointments and securing UK NHS reimbursement for another product, the UroShield kit, further underscored the company's push for both domestic market penetration and international revenue potential.
This analysis was generated using AI and real-time stock data. Always do your own research before making investment decisions.